Urolift & HTA from NICE
UroLift, a urethral lift implant for treating benign prostatic hyperplasia, was selected for NICE guidance. The technology went from being used in 4 hospitals to 15 within 6 months of guidance publication.
Read more About Urolift & HTA from NICE